Heterogeneity of circulating CD8 T-cells specific to islet, neo-antigen and virus in patients with type 1 diabetes mellitus

PLoS One. 2018 Aug 8;13(8):e0200818. doi: 10.1371/journal.pone.0200818. eCollection 2018.

Abstract

Auto-reactive CD8 T-cells play an important role in the destruction of pancreatic β-cells resulting in type 1 diabetes (T1D). However, the phenotype of these auto-reactive cytolytic CD8 T-cells has not yet been extensively described. We used high-dimensional mass cytometry to phenotype autoantigen- (pre-proinsulin), neoantigen- (insulin-DRIP) and virus- (cytomegalovirus) reactive CD8 T-cells in peripheral blood mononuclear cells (PBMCs) of T1D patients. A panel of 33 monoclonal antibodies was designed to further characterise these cells at the single-cell level. HLA-A2 class I tetramers were used for the detection of antigen-specific CD8 T-cells. Using a novel Hierarchical Stochastic Neighbor Embedding (HSNE) tool (implemented in Cytosplore), we identified 42 clusters within the CD8 T-cell compartment of three T1D patients and revealed profound heterogeneity between individuals, as each patient displayed a distinct cluster distribution. Single-cell analysis of pre-proinsulin, insulin-DRIP and cytomegalovirus-specific CD8 T-cells showed that the detected specificities were heterogeneous between and within patients. These findings emphasize the challenge to define the obscure nature of auto-reactive CD8 T-cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Autoantigens / immunology
  • Biomarkers / blood
  • CD8-Positive T-Lymphocytes / cytology*
  • CD8-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / physiology
  • Diabetes Mellitus, Type 1 / immunology*
  • Female
  • HLA-A2 Antigen / immunology
  • Humans
  • Insulin-Secreting Cells / immunology
  • Leukocytes, Mononuclear / immunology
  • Male
  • Phenotype
  • Single-Cell Analysis / methods

Substances

  • Autoantigens
  • Biomarkers
  • HLA-A2 Antigen

Grants and funding

This work was supported by Diabetesfonds Nederland, Stichting Diabetes Onderzoek Nederland, The Wanek Family Project for Type 1 Diabetes (BOR).